 |
인쇄하기
취소
|
Yuyu’s Uclid wins Korea's new drug development and technology awards
Yuyu Pharm’s Uclid, a combination of ticlopidine HCl and ginkgo biloba extract, has recently won the Grand Prize in Korea’s New Drug Development Award hosted by the Korean Drug Research Association (KDRA)
It took 10 years to develop Uclid since the company initiated its study, according to a Yuyu official. Uclid is effective in the treatment of cerebral apoplexy, myocardial infarction and c...
It took 10 years to develop Uclid since the company initiated its study, according to a Yuyu official. Uclid is effective in the treatment of cerebral apoplexy, myocardial infarction and c...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.